Berrey MM - Search Results

1

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection.

Malhotra U, Berrey MM, Huang Y, Markee J, Brown DJ, Ap S, Musey L, Schacker T, Corey L, McElrath MJ. Malhotra U, et al. Among authors: berrey mm. J Infect Dis. 2000 Jan;181(1):121-31. doi: 10.1086/315202. J Infect Dis. 2000. PMID: 10608758

2

Antiretroviral therapy in primary HIV.

Corey L, Berrey MM. Corey L, et al. Among authors: berrey mm. Adv Exp Med Biol. 1999;458:223-7. doi: 10.1007/978-1-4615-4743-3_21. Adv Exp Med Biol. 1999. PMID: 10549394 Review.

3

Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment.

Malhotra U, Holte S, Dutta S, Berrey MM, Delpit E, Koelle DM, Sette A, Corey L, McElrath MJ. Malhotra U, et al. Among authors: berrey mm. J Clin Invest. 2001 Feb;107(4):505-17. doi: 10.1172/JCI11275. J Clin Invest. 2001. PMID: 11181650 Free PMC article.

4

Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS.

Berrey MM, Schacker T, Collier AC, Shea T, Brodie SJ, Mayers D, Coombs R, Krieger J, Chun TW, Fauci A, Self SG, Corey L. Berrey MM, et al. J Infect Dis. 2001 May 15;183(10):1466-75. doi: 10.1086/320189. Epub 2001 Apr 24. J Infect Dis. 2001. PMID: 11319682 Clinical Trial.

5

Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.

Smith D, Berrey MM, Robertson M, Mehrotra D, Markowitz M, Perrin L, Clumeck N, Lazzarin A, Burckhardt B, Weber R, Corey L, Cooper DA. Smith D, et al. Among authors: berrey mm. J Infect Dis. 2000 Sep;182(3):950-4. doi: 10.1086/315753. Epub 2000 Aug 17. J Infect Dis. 2000. PMID: 10950796 Free article. Clinical Trial.

6

Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.

Boeckh M, Berrey MM, Bowden RA, Crawford SW, Balsley J, Corey L. Boeckh M, et al. Among authors: berrey mm. J Infect Dis. 2001 Aug 1;184(3):350-4. doi: 10.1086/322043. Epub 2001 Jun 28. J Infect Dis. 2001. PMID: 11443562 Clinical Trial.

7

Concordance between HIV source partner identification and molecular confirmation in acute retroviral syndrome.

Truong HM, Berrey MM, Shea T, Diem K, Corey L. Truong HM, et al. Among authors: berrey mm. J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):232-43. doi: 10.1097/00042560-200203010-00003. J Acquir Immune Defic Syndr. 2002. PMID: 11873072

8

Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

Chun TW, Engel D, Berrey MM, Shea T, Corey L, Fauci AS. Chun TW, et al. Among authors: berrey mm. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8869-73. doi: 10.1073/pnas.95.15.8869. Proc Natl Acad Sci U S A. 1998. PMID: 9671771 Free PMC article.

9

Cotton-wool spots in primary HIV infection.

Berrey MM, Shea T, Corey L. Berrey MM, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Oct 1;19(2):197-8. doi: 10.1097/00042560-199810010-00016. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9768632 No abstract available.

10

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.

Chun TW, Engel D, Mizell SB, Hallahan CW, Fischette M, Park S, Davey RT Jr, Dybul M, Kovacs JA, Metcalf JA, Mican JM, Berrey MM, Corey L, Lane HC, Fauci AS. Chun TW, et al. Among authors: berrey mm. Nat Med. 1999 Jun;5(6):651-5. doi: 10.1038/9498. Nat Med. 1999. PMID: 10371503 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page